FDA.reportPublic FDA data

1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol]

RxCUI
1743781
RxNorm name
1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol]
Display name
DEPO-Medrol (Injectable)
Full name
1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol]
Term type
SBD
Status
Active
Strength
40 mg/ml
Dose form
Injection 1 ml
Route
Injectable
Updated
2026-10-22 07:01:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042016
Active start
042016
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methylprednisolone acetate40 MG / 1 MLmethylprednisolonemethylprednisolone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methylprednisolone6902

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STR1 ML DEPO-Medrol 40 MG/ML Injection1NAMES
RxNorm Name1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
4 linked values
4CODES
RxCUI17437811CODES
MMSL_CODEMTH_RXN_BD23121CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0009-3073-010009-3073Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-3073-030009-3073Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-3073-220009-3073Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-3073-230009-3073Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
50090-2098-050090-2098DEPO-MEDROL methylprednisolone acetateA-S Medication SolutionsNDA011757

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0117570009-3073Depo-Medrol methylprednisolone acetateNDAPharmacia & Upjohn Company LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 10 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00009307301rxnav_ndcsyes
00009307303rxnav_ndcsyes
00009307322rxnav_ndcsyes
00009307323rxnav_ndcsyes
50090209800rxnav_ndcsyes
49349094801rxnav_historical
54569221300rxnav_historical
54569394600rxnav_historical
55154392905rxnav_historical
70518051600rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLC9a7b3837-e038-48bf-97e9-78ad463760dc2026-01-21Warnings, Adverse reactionsExact identifier
ndc (package): 0009-3073-01
ndc (package): 0009-3073-03
ndc (product): 0009-3073
ndc11 (package): 00009307303
ndc11 (package): 00009307301
rxcui: 1743781
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLCbf1b104d-85cb-414d-a366-78068c82c8832025-12-01Warnings, Adverse reactionsExact identifier
ndc (package): 0009-3073-22
ndc (package): 0009-3073-23
ndc (product): 0009-3073
ndc11 (package): 00009307323
ndc11 (package): 00009307322
rxcui: 1743781
DEPO-MEDROLMETHYLPREDNISOLONE ACETATEA-S Medication Solutionscb457bef-8823-4f3c-987b-eb0922494c462025-11-06Warnings, Adverse reactionsExact identifier
ndc (package): 50090-2098-0
ndc (product): 50090-2098
ndc11 (package): 50090209800
rxcui: 1743781

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-Medrol 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol] [SBD] · 1 ML Depo-Medrol 40 MG/ML Injection [SY] · Depo-Medrol 40 MG per 1 ML Injection [SY]427DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20260121
cb457bef-8823-4f3c-987b-eb0922494c46DEPO-Medrol 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol] [SBD] · 1 ML Depo-Medrol 40 MG/ML Injection [SY] · Depo-Medrol 40 MG per 1 ML Injection [SY]420DEPO-MEDROL20251106
bf1b104d-85cb-414d-a366-78068c82c883DEPO-Medrol 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol] [SBD] · 1 ML Depo-Medrol 40 MG/ML Injection [SY] · Depo-Medrol 40 MG per 1 ML Injection [SY]417DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20251201
92cb6339-75ab-48eb-b304-19db59695883DEPO-Medrol 40 MG in 1 ML Injection [PSN] · 1 ML methylprednisolone acetate 40 MG/ML Injection [Depo-Medrol] [SBD] · 1 ML Depo-Medrol 40 MG/ML Injection [SY] · Depo-Medrol 40 MG per 1 ML Injection [SY]41DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20140205

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20260121
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251217
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251201
cb457bef-8823-4f3c-987b-eb0922494c46DEPO-MEDROLA-S Medication Solutions20251106
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251008
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251006
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20250828
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20250818
cb457bef-8823-4f3c-987b-eb0922494c46DEPO-MEDROLA-S Medication Solutions20240207
754e9384-f4d4-70cf-e053-2a91aa0a9748Point Of Care Kit LM-DEP-2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Bupivacaine HCI safely and effectively. See full prescribing information for Bupivacaine HCI. Bupivacaine HCI Injectables, USP Initial U.S. Approval:2013NuCare Pharmaceuticals,Inc.20210504
72dcd99f-59e3-a11f-e053-2a91aa0a4bd3DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)NuCare Pharmaceuticals,Inc.20210504
30c7a341-d9fe-40f7-a10d-818df572f5dfDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)REMEDYREPACK INC.20201118
92cb6339-75ab-48eb-b304-19db59695883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Proficient Rx LP20140205
b0bc7e16-1801-42c2-a1f5-1dbaf8a8b6e5National Council for Prescription Drug Programs20120724
a87c022e-a1a3-4fc7-83b5-545b9db82031National Council for Prescription Drug Programs20120724
292a8e6c-a5a0-4ffc-ad29-22641e1484d6National Council for Prescription Drug Programs20120724
f2c67ef7-89c4-454b-bf7c-539fb4856011National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AACorticosteroids, combinations for treatment of acneATC1-4methylprednisolone
ATCD07AACorticosteroids, weak (group I)ATC1-4methylprednisolone
ATCH02ABGlucocorticoidsATC1-4methylprednisolone
FDASPLN0000175576CorticosteroidEPChas_epcmethylprednisolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTD008775MethylprednisoloneCHEMhas_ingredientmethylprednisolone
MEDRTD000077555Methylprednisolone AcetateCHEMhas_ingredientmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone acetate
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone acetate
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone acetate
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone acetate
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone acetate
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone acetate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone acetate
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone acetate
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone acetate
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD007223InfantDISEASEci_withmethylprednisolone
MEDRTD007223InfantDISEASEci_withmethylprednisolone acetate
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone acetate
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone
MEDRTD009181MycosesDISEASEci_withmethylprednisolone acetate
MEDRTD009181MycosesDISEASEci_withmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone acetate
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone acetate
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone acetate
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone acetate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH40 MG/ML (expressed as methylprednisolone acetate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY1 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA011757
NAMESPrescribable SynonymDEPO-Medrol 40 MG in 1 ML Injection
NAMESTallman Synonym1 ML DEPO-Medrol 40 MG/ML Injection
NAMESTallman Synonym1 ML methylPREDNISolone acetate 40 MG/ML Injection [DEPO-Medrol]
NAMESTallman SynonymDEPO-Medrol 40 MG per 1 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon